Is it time to reexamine the patent system's role in spending growth?

Health Affairs

Volumn 28, Issue 5, 2009, Pages 1466-1474

  Pauly, Mark V ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; HEALTH CARE COST; HEALTH CARE POLICY; MEDICAL CARE; MEDICAL TECHNOLOGY; PATENT;

COMPARATIVE EFFECTIVENESS RESEARCH; COST CONTROL; HEALTH EXPENDITURES; HEALTH POLICY; INTELLECTUAL PROPERTY; PATENTS AS TOPIC; TECHNOLOGY, HIGH-COST;

EID: 70349216725     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.5.1466     Document Type: Article

References (12)

1. Smith S, Heffler SK, Calfo S, Clemens K, Freeland M, Seifert ML, et al. National health projections through 2008. Health Care Financ Rev. 1999;21(2):211-237
2. Cutler DM. The cost and financing of health care. Am Econ Rev. 1995;85(2):32-37
3. Newhouse JP. Medical care costs: How much welfare loss? J Econ Perspect. 1992; 6(1):3-21.
4. Obama B. Presidential address to joint session of Congress, 2009 Feb 24 [Internet]. Washington (DC): White House; 2009 Feb 24 [cited 2009 Jun 22]. Available from: http://www.whitehouse.gov/the-press-office/remarks-of-president- barack-obama-address-to-joint-session-of-congress/
5. Thomas L. The technology of medicine. In: Lives of a cell: notes of a biologywatcher. New York (NY): Viking Press; 1974. p. 31-36
6. Baumgardner JR. The interaction between forms of insurance contract and types of technical change in medical care. RAND J Econ. 1991;22(1):36-53.
7. Califf RM. Defining the balance of risk and benefit in the era of genomics and proteomics. Health Aff (Millwood). 2004;23(1):77-87.
8. Newhouse JP, Insurance Experiment Group. Free for all? Lessons from the RAND Health Insurance Experiment. Cambridge (MA): Harvard University Press; 1993.
9. Pauly MV. Means-testing in Medicare. Health Aff (Millwood) 2004;23:w4-546-557
10. Pauly MV. Markets without magic: how competition might save Medicare. Washington (DC): AEI Press; 2008.
11. Hall RE, Jones CI. The value of life and the rise in health spending. Q J Econ. 2007;122(1):39-72.
12. Kremer M, Glennerster R. Strong medicine: creating incentives for pharmaceutical research on neglected diseases. Princeton (NJ): Princeton University Press; 2004.